A collaboration agreement was signed at SPIEF-21 to reconstruct a plant for the production of dry adapted milk mixtures and dry milk base, with an investment of 3.8 billion rubles. The plant, set to complete by Q2 2023, will produce 16.6 thousand tons of breast milk substitutes annually, creating over 120 new jobs and increasing Russia's domestic production to reduce dependence on imports. The products will be distributed across the Russian Federation and CIS countries. CJSC Infaprim, the domestic manufacturer of food for children under 6 and the sole Russian manufacturer of food for the sick and those with rare genetic diseases, is leading the project.